Wiland P, Both C, Gaylis N, Cohen R, Halfvarson J, Lemke L
Adv Ther. 2025; 42(3):1360-1392.
PMID: 39907897
DOI: 10.1007/s12325-024-03098-z.
Fan Y, Feng R, Zhang X, Wang Z, Xiong F, Zhang S
Acta Pharm Sin B. 2024; 14(8):3362-3384.
PMID: 39220863
PMC: 11365444.
DOI: 10.1016/j.apsb.2024.04.006.
Liu D, Li X, Zhang L, Hu B, Hu S, Zhang X
Front Physiol. 2023; 14:1156913.
PMID: 37089415
PMC: 10119395.
DOI: 10.3389/fphys.2023.1156913.
Hoing A, Struth R, Beuck C, Rafieiolhosseini N, Hoffmann D, Stauber R
RSC Adv. 2022; 12(53):34176-34184.
PMID: 36545626
PMC: 9709806.
DOI: 10.1039/d2ra06019a.
Franco Malange K, Navia-Pelaez J, Dias E, Borges Paes Lemes J, Choi S, Dos Santos G
Front Pain Res (Lausanne). 2022; 3:1018800.
PMID: 36387416
PMC: 9644179.
DOI: 10.3389/fpain.2022.1018800.
Visceral adiposity, inflammation, and hippocampal function in obesity.
Stranahan A
Neuropharmacology. 2021; 205:108920.
PMID: 34902347
PMC: 8958382.
DOI: 10.1016/j.neuropharm.2021.108920.
4-(2,5-Dimethyl-1H-pyrrol-1-yl)-N-(2,5-dioxopyrrolidin-1-yl) benzamide improves monoclonal antibody production in a Chinese hamster ovary cell culture.
Aki Y, Katsumata Y, Kakihara H, Nonaka K, Fujiwara K
PLoS One. 2021; 16(4):e0250416.
PMID: 33886677
PMC: 8061942.
DOI: 10.1371/journal.pone.0250416.
Emerging Roles of Vascular Cell Adhesion Molecule-1 (VCAM-1) in Immunological Disorders and Cancer.
Kong D, Kim Y, Kim M, Jang J, Lee S
Int J Mol Sci. 2018; 19(4).
PMID: 29614819
PMC: 5979609.
DOI: 10.3390/ijms19041057.
Efficacy and safety of adalimumab by intra-articular injection for moderate to severe knee osteoarthritis: An open-label randomized controlled trial.
Wang J
J Int Med Res. 2017; 46(1):326-334.
PMID: 28840750
PMC: 6011328.
DOI: 10.1177/0300060517723182.
Targeting Tumor Necrosis Factor-α with Adalimumab: Effects on Endothelial Activation and Monocyte Adhesion.
Oberoi R, Schuett J, Schuett H, Koch A, Luchtefeld M, Grote K
PLoS One. 2016; 11(7):e0160145.
PMID: 27467817
PMC: 4965117.
DOI: 10.1371/journal.pone.0160145.
Challenges in Antibody Development against Tn and Sialyl-Tn Antigens.
Loureiro L, Carrascal M, Barbas A, Ramalho J, Novo C, Delannoy P
Biomolecules. 2015; 5(3):1783-809.
PMID: 26270678
PMC: 4598775.
DOI: 10.3390/biom5031783.
Femtomolar Fab binding affinities to a protein target by alternative CDR residue co-optimization strategies without phage or cell surface display.
Votsmeier C, Plittersdorf H, Hesse O, Scheidig A, Strerath M, Gritzan U
MAbs. 2012; 4(3):341-8.
PMID: 22531438
PMC: 3355236.
DOI: 10.4161/mabs.19981.
Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis.
Potter C, Hyrich K, Tracey A, Lunt M, Plant D, Symmons D
Ann Rheum Dis. 2008; 68(1):69-74.
PMID: 18375541
PMC: 2596303.
DOI: 10.1136/ard.2007.084715.
Genetic, cellular and immune approaches to disease therapy: past and future.
Nabel G
Nat Med. 2004; 10(2):135-41.
PMID: 14760423
PMC: 7095815.
DOI: 10.1038/nm990.
